News

August 12, 2020August 12, 2020

XPro1595 Lowers Neuroinflammation in Mild to Moderate Alzheimer’s, Interim Results Show

News

XPro1595, an investigational therapy by INmune Bio, can lower brain inflammation in people with mild to moderate Alzheimer’s disease, according to interim results of a clinical trial. Specifically, the ... Read more

August 10, 2020August 10, 2020

Aducanumab Wins FDA Priority Review, Moves Closer to US Approval

News

The U.S. Food and Drug Administration (FDA) has accepted and given priority review designation to Biogen‘s application requesting the approval of aducanumab (BIIB037) for the treatment of Alzheimer’s disease. While the Prescription ... Read more

August 3, 2020August 3, 2020

Trial of Potential Alzheimer’s Vaccine Advances to Medium Dose Group

News

Testing of a second and higher dose of ACI-35.030, a potential Alzheimer’s vaccine, is now beginning in a Phase 1b/2a clinical trial, AC Immune announced. Positive interim safety, tolerability, and specificity results from ... Read more

July 27, 2020July 27, 2020

Flu, Pneumonia Vaccinations Linked to Reduced Risk of Alzheimer’s, Researchers Say

News

Vaccines against the flu and pneumonia are associated with a lower risk of developing Alzheimer’s disease, while infections are generally linked to increased mortality among people with dementia, according ... Read more

July 22, 2020July 22, 2020

FDA to Consider Nuplazid to Treat Dementia-related Psychosis

News

The U.S. Food and Drug Administration (FDA) has accepted a request by Acadia Pharmaceuticals‘ that Nuplazid (pimavanserin) be approved for a new indication: the treatment of delusions and hallucinations associated ... Read more

July 20, 2020July 20, 2020

Global Phase 3 Trial Will Test BAN2401 in Early-stage Asymptomatic Alzheimer’s

News

BAN2401, an experimental treatment for Alzheimer’s disease (AD), will be tested in the new global AHEAD 3-45 clinical trial, its developers have announced. The Phase 3 study — to ... Read more

July 15, 2020July 15, 2020

Alzheimer’s Foundation Expands Toll-free Helpline to Support Patients, Caregivers

News

The Alzheimer’s Foundation of America (AFA) is expanding the availability of its National Toll-Free Helpline — adding weekend hours as well as chat and message features in dozens of ... Read more

July 13, 2020July 13, 2020

Biogen, Eisai Seek FDA Approval of Aducanumab for Alzheimer’s

News

Biogen and Eisai have submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) requesting the approval of aducanumab (BIIB037) for the treatment of Alzheimer’s ... Read more

July 8, 2020July 8, 2020

Foundation Offers Free Online Memory Screenings

News

To promote brain health, the Alzheimer’s Foundation of America (AFA) is offering free online memory screenings that people can participate in from home. The confidential screenings — part of ... Read more

July 6, 2020July 6, 2020

AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

News

AlzeCure Pharma announced positive results from its first clinical study of ACD856 for the potential treatment of Alzheimer’s disease. According to the company, ACD856 showed a good pharmacokinetic profile ... Read more

Pin It on Pinterest